Upload Avatar (500 x 500)
Lu-Wen Shi
shilu@bjmu.edu.cn
English, Chinese
Beijing
Peking University
Pharmaceutical Sciences
  • 1992 - Master's in Medical Education Management: University of Illinois at Chicago
  • 1987 - Bachelor's in Science: Beijing Medical University
  • 2000.04-2019.12 - Peking University School of Pharmaceutical Sciences - Professor, Director
  • 2002.12-present - Peking University International Research Center for Medical Management - Director, Researcher
  • 2005.09-2006.08 - Beijing Municipal Health Bureau - Assistant to the Director
  • 2000.04-2005.11 - Peking University Health Science Center - Deputy Director, Party Committee Member
  • 1997.03-2000.03 - Beijing Medical University Logistics and Infrastructure Department - Director, Deputy Secretary of the Logistics Party Committee
  • 1992.03-1997.03 - Beijing Medical University School of Pharmaceutical Sciences - Deputy Dean, Secretary of the Office Branch
  • 1992.05-2000.03 - Beijing Medical University School of Pharmaceutical Sciences - Director of the Department of Pharmaceutical Management, Deputy Director of the Department of Clinical Pharmacy, Associate Professor
  • 2021 - Peking University Health Science Center 2021 Zhongwai Medical Award
  • 2021 - Peking University Health Science Center Teaching Achievement Award (Second Prize)
  • 2021 - Peking University Fifth Industry-University-Research Project Cooperation Advanced Individual
  • 2020 - Peking University Health Science Center Sixth 'Good Teacher and Helpful Friend'
  • 2019 - Peking University Continuing Education Teaching Excellence Award
  • 2018 - Main Contributor to the Seventh 'Xue Muqiao Price Research Award', 'Research on Low-Priced Drug Price Issues'
  • 2018 - Peking University Health Science Center 'Excellent Visiting Scholar Mentor' Honor
  • 2018 - Peking University Health Science Center 'Advanced Individual in Teacher Ethics' Honor
  • 2018 - 'Most Concerned Medical Reform Expert of 2018' Honor
  • 2012 - 'Scientific Chinese (2011) Person of the Year' Honor
  • 2008 - China Price Association Outstanding Achievement Award
  • 1997 - Beijing Higher Education Teaching Achievement Award (Second Prize)
  • 1995 - National Education Commission Science and Technology Progress Award (First Prize)
  • 1992 - National Administration of Traditional Chinese Medicine Science and Technology Progress Award (Second and Third Prizes)
Development and Reform Strategies of China's Pharmaceutical and Health Services
Pharmaceutical Policy and Law
Pharmaceutical Industry Development Strategies
Pharmacy Teaching Management and Reform
Development and Teaching Practice System of Pharmaceutical Management and Clinical Pharmacy
Drug Utilization and Pharmacoeconomics
Medication Behavior
Pharmacy Services and Evaluation System
  • Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States, Zhang Y, Katharina Wagner A, Du H, Han T, Gupta S, Denburg AE, Frazier AL, Guan X, Shi L*, 2022
  • Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China, Fu M, Wushouer H, Hu L, Li N, Guan X, Shi L*, Ross-Degnan D, 2021
  • Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis, Wei G, Wu M, Zhu H, Han S, Chen J, Zhai C, Shi L*, 2021
  • Impact of house price growth on mental health: Evidence from China, Wei G, Zhu H, Han S, Chen J, Shi L*, 2020
  • Risk of Liver Injury Associated with Intravenous Lipid Emulsions: A Prescription Sequence Symmetry Analysis, Li XX, Cheng YC, Zhai SD, Yao P, Zhan SY, Shi L*W, 2021
  • Response Letter to 'Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China', Guan H, Sheng Y, Guo W, Han S, Shi L*, 2020
  • Differences in reimbursement listing of anticancer therapies in China: an observational study, Guan X, Zhang Y, Wushouer H, Shi L*, Ross-Degnan D, Wagner AK, 2020
  • The Impact of Physicians' Working Hours on Inappropriate Use of Outpatient Medicine in a Tertiary Hospital in China, Guan X, Ni B, Zhang J, Man C, Cai Z, Meng W, Shi L*, Ross-Degnan D, 2019
  • Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study, Guan X, Wushouer H, Yang M, Han S, Shi L*, Ross-Degnan D, Wagner AK, 2019
  • Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China, Guan H, Liu G, Xie F, Sheng Y, Shi L*, 2019
Pharmaceutical Health Services Reform Policy Law Industry Development Teaching Management Clinical Pharmacy Pharmacoeconomics Evaluation System

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.